Sign in

    Brian Hartzband

    Research Analyst at Private Investor

    Brian Hartzband is an independent private investor and analyst, formerly serving on the board of AlphaVest Acquisition Corp, where he guided investment strategies and company oversight. His career includes governance roles and direct investments, notably in TenX, though no significant corporate analyst coverage or performance metrics are publicly documented. Hartzband's professional background centers on private investment and board advisory, with a recent resignation from his director role at AlphaVest in late 2024. There is no public record of FINRA securities licenses, notable rankings, or major industry accolades related to sell-side equity research.

    Brian Hartzband's questions to Bon Natural Life (BON) leadership

    Brian Hartzband's questions to Bon Natural Life (BON) leadership • H1 2022

    Question

    Brian Hartzband, a Private Investor, inquired about the factors driving the increase in average selling prices and the outlook for this trend. He also asked for the company's fiscal 2022 guidance and an update on the new Yumen plant's timeline and expected financial contribution.

    Answer

    Chairman and CEO Yongwei Hu attributed the price increases to global inflation and supply chain disruptions, stating the company successfully passed these costs to customers and expects the trend to hold. CFO Zhenchao Li projected that the approximate 17% revenue and net income growth from H1 would continue for the remainder of the fiscal year. Mr. Hu also confirmed the new Yumen plant is on schedule and is expected to increase production capacity by 200% and revenue by 150% over two years.

    Ask Fintool Equity Research AI